Celldex Therapeutics (CLDX) investor relations material

Opening remarks and agenda

• Meeting held virtually, with reminders about forward-looking statements and SEC regulations.

• Introduction of board members, auditors, and key executives in attendance.

• Confirmation that only four proposals, as outlined in the proxy statement, would be considered.

• Quorum established with over 65 million shares represented.

Board and executive committee updates

• All current directors nominated for re-election, with motions and seconds for each proposal.

Shareholder proposals

• Four proposals presented: election of directors, ratification of auditors, amendment to equity plan, and advisory vote on executive compensation.

• No additional shareholder proposals were submitted in advance.